Basics OmniAb, Inc. IPO Date: September 30, 2021 Sector: Healthcare Industry: Biotech Market Cap: $172.49M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 2.62% Avg Daily Range (30 D): $0.05 | 3.46% Avg Daily Range (90 D): $0.07 | 3.08% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): 1.01M Avg Daily Volume (90 D): .73M Trade Size Avg Trade Size (Sh.): 114 Avg Trade Size (Sh.) (30 D): 187 Avg Trade Size (Sh.) (90 D): 137 Institutional Trades Total Inst.Trades: 104 Avg Inst. Trade: $1.48M Avg Inst. Trade (30 D): $.85M Avg Inst. Trade (90 D): $1.49M Avg Inst. Trade Volume: .45M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.62M Avg Closing Trade (30 D): $1.31M Avg Closing Trade (90 D): $2.6M Avg Closing Volume: 442.48K     News May 5, 2025 @ 4:59 PM VERAXA Biotech Enters Co-discovery Alliance with O... Source: N/A Apr 30, 2024 @ 9:55 PM USANA Health Sciences (USNA) Q1 Earnings and Reven... Source: Zacks Equity Research Mar 26, 2024 @ 12:40 PM Over $1M Bet On OmniAb? Check Out These 3 Stocks I... Source: Avi Kapoor Mar 5, 2024 @ 10:35 PM Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Rev... Source: Zacks Equity Research Feb 29, 2024 @ 1:40 PM Karyopharm Therapeutics (KPTI) Reports Q4 Loss, To... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.59 $-.17 $-.13 Diluted EPS $-.59 $-.17 $-.13 Revenue $ 26.74M $ 4.15M $ 10.8M Gross Profit $ $ $ Net Income / Loss $ -61.27M $ -18.2M $ -13.07M Operating Income / Loss $ -70.79M $ -18.84M $ -15.88M Cost of Revenue $ $ $ Net Cash Flow $ -8.17M $ -16.71M $ .36M PE Ratio